Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 3015-3020

  Liu, Ling ^a   Ling, Jing ^b   Ma, Zhenni ^a   Yuan, Quan ^a   Pan, Jun ^a   Yang, Huilin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

A disintegrin and metalloproteinase with thrombospondin motif; Member 13; Total hip arthroplasty; Total knee arthroplasty; Venous thrombosis embolism; Von Willebrand factor

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOMATION; BLOOD CLOTTING; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGY ANALYZER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTHROMBIN TIME; THROMBIN TIME; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WESTERN BLOTTING; ADVERSE EFFECTS; ARTHROPLASTY; BLOOD; BLOOD CLOTTING TEST; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; VERY ELDERLY;

ADAM PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; VON WILLEBRAND FACTOR;

EID: 84921325838     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3041     Document Type: Article

References (30)

1. Anderson JA, Lim W and Weitz JI: Genetics of coagulation: what the cardiologist needs to know. Can J Cardiol 29: 75-88, 2013.
2. Fisher WD: Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. Can J Surg 54: 344-351, 2011.
3. Falck-Ytter Y, Francis CW, Johanson NA, et al; American College of Chest Physicians: Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (2 Suppl): e278S-e325S, 2012.
4. Barrack RL: Current guidelines for total joint VTE prophylaxis: dawn of a new day. J Bone Joint Surg Br 94 3-7, 2012.
5. Sadler JE von Willebrand factor: two sides of a coin. J Thromb Haemost 3: 1702-1709, 2005
6. Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE and Fujikawa K: Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276: 41059-41063, 2001.
7. Porter S, Clark IM, Kevorkian L and Edwards DR: The ADAMTS metalloproteinases. Biochem J 386: 15-27, 2005
8. Tsai HM: Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87 4235-4244, 1996.
9. Furlan M, Robles R and Lämmle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 4223-4234, 1996.
10. Fujikawa K, Suzuki H, McMullen B and Chung D: Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98: 1662-1666, 2001.
11. Koster T, Blann AD, Briet E, Vandenbroucke JP and Rosendaal FR: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345: 152-155, 1995
12. Tsai AW, Cushman M, Rosamond WD, et al: Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113: 636-642, 2002.
13. Wang AY, Liu F, Ma ZN, Dong NZ, Zhang JY and Ruan CG: Research on the C-terminal domain of ADAMTS13 regulates its cleaving activity. Zhonghua Xue Ye Xue Za Zhi 31: 830-834, 2010 (In Chinese).
14. Kokame K, Nobe Y, Kokubo Y, Okayama A and Miyata T: FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129: 93-100, 2005
15. Ruan CG, Xi XD and Gu JM: Studies on monoclonal antibodies to human von Willebrand factor. Zhonghua Nei Ke Za Zhi 25: 547-550, 1986 (In Chinese).
16. Zhao Y, Gu Y, Ji S, Yang J, Yu Z and Ruan C: Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease. Eur J Haematol 88: 439-445, 2012.
17. Clarke MT, Green JS, Harper WM and Gregg PJ: Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis. J Bone Joint Surg Br 79: 787-791, 1997
18. Piovella F, Wang CJ, Lu H, et al: Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 3: 2664-2670, 2005.
19. Spirin VA, Khomenko NM and Vasil'kov VG: Hemostasis system in patients with bile duct diseases undergoing surgery under peridural anesthesia and neuroleptanalgesia. Anesteziol Reanimatol: 55-57, 1982 (In Russian).
20. Bergqvist D: Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients. Pathophysiol Haemost Thromb 33: 358-361, 2003.
21. Müller R and Musikić P: Hemorheology in surgery - a review. Angiology 38: 581-592, 1987
22. Picker SM: In-vitro assessment of platelet function. Transfus Apher Sci 44 305-319, 2011.
23. Lindberg F, Rasmussen I, Siegbahn A and Bergqvist D: Coagulation activation after laparoscopic cholecystectomy in spite of thromboembolism prophylaxis. Surg Endosc 14: 858-861, 2000.
24. El Kady N, Khedr H, Yosry M and El Mekawi S: Perioperative assessment of coagulation in paediatric neurosurgical patients using thromboelastography. Eur J Anaesthesiol 26: 293-297, 2009
25. Schietroma M, Carlei F, Mownah A, et al: Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy. Surg Endosc 18: 1090-1096, 2004
26. Goobie SM, Soriano SG, Zurakowski D, McGowan FX and Rockoff MA: Hemostatic changes in pediatric neurosurgical patients as evaluated by thrombelastograph. Anesth Analg 93: 887-892, 2001.
27. Lison S, Weiss G, Spannagl M and Heindl B: Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 22: 190-196, 2011.
28. Sadler JE: von Willebrand factor assembly and secretion. J Thromb Haemost 7 Suppl 1: 24-27, 2009
29. Geerts WH, Pineo GF, Heit JA, et al: Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 338S-400S, 2004.
30. Zhao YM, Jiang M, Ji SD, et al: Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys. Biochem Pharmacol 85: 945-953, 2013.